Literature DB >> 2843271

A comparative study of virulent and avirulent strains of Chromobacterium violaceum.

D P Miller1, W T Blevins, D B Steele, M D Stowers.   

Abstract

A clinical isolate and a soil isolate of Chromobacterium violaceum were compared to determine differences in virulence-related characteristics. Purified lipopolysaccharide (endotoxin) from the virulent, clinical strain was more reactive than that from the avirulent soil strain as determined by the Limulus amebocyte lysate assay. There were no differences in hemolysin or cyanide production between the two strains. The virulent strain was more resistant to phagocytosis and intracellular killing by human polymorphonucleocytes. The clinical strain showed a superoxide dismutase activity 30% higher and a catalase activity fivefold higher than the activities of the soil-isolated strain. The clinical strain also was capable of producing approximately twice as much hydrogen peroxide during growth as compared with the soil isolate. This study suggests that virulence of C. violaceum may be, at least in part, associated with endotoxin, and some protection of the virulent, clinical strain from phagocytic attack is afforded by elevated levels of superoxide dismutase and catalase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843271     DOI: 10.1139/m88-046

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  8 in total

1.  The Spectrum of Chromobacterium violaceum Infections from a Single Geographic Location.

Authors:  Yi dan Lin; Suman S Majumdar; Jann Hennessy; Robert W Baird
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

2.  Diversity in antifungal activity of strains of Chromobacterium violaceum from the Brazilian Amazon.

Authors:  Eriana Serpa Barreto; Adalgisa Ribeiro Torres; Marliton Rocha Barreto; Ana Tereza Ribeiro Vasconcelos; Spartaco Astolfi-Filho; Mariangela Hungria
Journal:  J Ind Microbiol Biotechnol       Date:  2008-03-18       Impact factor: 3.346

3.  The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability.

Authors: 
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-18       Impact factor: 11.205

4.  Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice.

Authors:  Brahm H Segal; Li Ding; Steven M Holland
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

5.  Identification of secreted virulence factors of Chromobacterium violaceum.

Authors:  Thiago Castro-Gomes; Mariana S Cardoso; Wanderson D DaRocha; Letícia A Laibida; Andréa M A Nascimento; Luciana W Zuccherato; Maria Fátima Horta; Marcelo P Bemquerer; Santuza M R Teixeira
Journal:  J Microbiol       Date:  2014-02-17       Impact factor: 3.422

6.  Chromobacterium violaceum in Northern Australia: A Sheep in Wolf's Clothing?

Authors:  Alice Young; Simon Smith; Peter Horne; Bronwyn Thomsett; Josh Hanson
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

7.  Agricultural Injury-Associated Chromobacterium violaceum Infection in a Bangladeshi Farmer.

Authors:  Razib Mazumder; Tuhin Sadique; Debashis Sen; Palash Mozumder; Tania Rahman; Anup Chowdhury; Farhana Halim; Nasrin Akter; Dilruba Ahmed
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

8.  Constraints-based analysis identifies NAD+ recycling through metabolic reprogramming in antibiotic resistant Chromobacterium violaceum.

Authors:  Deepanwita Banerjee; Anu Raghunathan
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.